Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients

類似資料

• The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy
  著者:: Adamczyk, Bożena, 等
  出版事項: (2017)
• Safety and Efficacy of Fingolimod and Natalizumab in Multiple Sclerosis After the Failure of First-Line Therapy: Single Center Experience Based on the Treatment of Forty-Four Patients
  著者:: Puz, Przemysław, 等
  出版事項: (2016)
• Cladribine tablets as therapy for advanced relapsing-remitting multiple sclerosis: a 4-year follow-up real-world, multi-center, retrospective, cohort study
  著者:: Aleksandra Pogoda-Wesołowska, 等
  出版事項: (2025-07-01)
• Elevated factor VIII level and stroke in patients without traditional risk factors associated with cardiovascular diseases
  著者:: Anetta, Lasek-Bal, 等
  出版事項: (2013)
• Patent foramen ovale and cryptogenic stroke – a statistical or cause-and-effect relationship? A neurological point of view
  著者:: Lasek-Bal, Anetta, 等
  出版事項: (2013)